English

Neuro Biotech Corp

EDGAR

Quarterly report (10-Q) · filed 2011-02-09

68 filing records in this dataset, filed from 1996-08-08 to 2011-02-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2010-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 0 USD 2010-12-31 Source
Exact value

0 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Revenue: 0 USD · 2009-04-01 – 2010-03-31 Source
Revenue: 0 USD · 2009-04-01 – 2009-12-31 Source
Revenue: 0 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 0 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 0 USD · 2010-10-01 – 2010-12-31 Source

Net income

-50.3 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Net income: -273402 USD · 2009-04-01 – 2010-03-31 Source
Net income: -154818 USD · 2009-04-01 – 2009-12-31 Source
Net income: -50081689 USD · 2010-04-01 – 2010-06-30 Source
Net income: -76916 USD · 2010-07-01 – 2010-09-30 Source
Net income: -55688 USD · 2010-10-01 – 2010-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-02-09.

Financial data available through: 2010-03-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-03-31
operating income: No compatible figures in this window
Net income: 11 of 11 periods available· newest 2010-03-31
Operating cash flow: 4 of 11 periods available· newest 2008-03-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2010-03-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2010-03-31
Current liabilities: 11 of 11 periods available· newest 2010-03-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2008-04-01 – 2009-03-31
Current period

USD 0

2009-04-01 – 2010-03-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
0 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Neuro Biotech Corp · 2010-03-31 Neuro Biotech Corp (edgar:894561) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#2201 Input fundies:Revenue: 0 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#2201
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 169,886

Prior period

−USD 443,288

2008-04-01 – 2009-03-31
Current period

−USD 273,402

2009-04-01 – 2010-03-31

Exact inputs and evidence

-273402 − -443288 = 169886 USD

-443288 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
-273402 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Neuro Biotech Corp · 2010-03-31 Neuro Biotech Corp (edgar:894561) Year-over-year change in Net income: 169886 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -273402 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#3578 Input fundies:NetIncome: -443288 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#3578
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-04-01 – 2010-03-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 273,402

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	Unavailable	Unavailable	Unavailable	-65516	Unavailable	Source 2001-01-01 – 2001-12-31: 0 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -65516 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -71429 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	Unavailable	Unavailable	Unavailable	575108	Unavailable	Source 2002-01-01 – 2002-12-31: 0 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 575108 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -28153 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	Unavailable	Unavailable	Unavailable	-18978	Unavailable	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -18978 USD Inspect Net Income Open source
2004 2004-01-01 – 2004-12-31	Unavailable	Unavailable	Unavailable	-24166	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -24166 USD Inspect Net Income Open source
2005 2004-04-01 – 2005-03-31	Unavailable	Unavailable	Unavailable	-43269	Unavailable	Source 2004-04-01 – 2005-03-31: 0 USD Inspect Revenue Open source 2004-04-01 – 2005-03-31: -43269 USD Inspect Net Income Open source
2006 2005-04-01 – 2006-03-31	Unavailable	Unavailable	Unavailable	-206540	Unavailable	Source 2005-04-01 – 2006-03-31: 0 USD Inspect Revenue Open source 2005-04-01 – 2006-03-31: -206540 USD Inspect Net Income Open source
2007 2006-04-01 – 2007-03-31	Unavailable	Unavailable	Unavailable	-805534	Unavailable	Source 2006-04-01 – 2007-03-31: 0 USD Inspect Revenue Open source 2006-04-01 – 2007-03-31: -805534 USD Inspect Net Income Open source 2006-04-01 – 2007-03-31: -26844 USD Inspect Operating Cash Flow Open source
2008 2007-04-01 – 2008-03-31	Unavailable	Unavailable	Unavailable	-5367187	Unavailable	Source 2007-04-01 – 2008-03-31: 0 USD Inspect Revenue Open source 2007-04-01 – 2008-03-31: -5367187 USD Inspect Net Income Open source 2007-04-01 – 2008-03-31: -98256 USD Inspect Operating Cash Flow Open source
2009 2008-04-01 – 2009-03-31	Unavailable	Unavailable	Unavailable	-443288	Unavailable	Source 2008-04-01 – 2009-03-31: 0 USD Inspect Revenue Open source 2008-04-01 – 2009-03-31: -443288 USD Inspect Net Income Open source
2010 2009-04-01 – 2010-03-31	Unavailable	Unavailable	Unavailable	-273402	Unavailable	Source 2009-04-01 – 2010-03-31: 0 USD Inspect Revenue Open source 2009-04-01 – 2010-03-31: -273402 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2010

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20012001-12-31	Revenue	Revenue: 0 Open source
20022002-12-31	Revenue	Revenue: 0 Open source
20032003-12-31	Revenue	Revenue: 0 Open source
20042004-12-31	Revenue	Revenue: 0 Open source
20052005-03-31	Revenue	Revenue: 0 Open source
20062006-03-31	Revenue	Revenue: 0 Open source
20072007-03-31	Revenue	Revenue: 0 Open source
20082008-03-31	Revenue	Revenue: 0 Open source
20092009-03-31	Revenue	Revenue: 0 Open source
20102010-03-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20052005-03-31	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20072007-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Operating margin	Not reported	Revenue: 0 Open source
2002-12-31	Operating margin	Not reported	Revenue: 0 Open source
2003-12-31	Operating margin	Not reported	Revenue: 0 Open source
2004-12-31	Operating margin	Not reported	Revenue: 0 Open source
2005-03-31	Operating margin	Not reported	Revenue: 0 Open source
2006-03-31	Operating margin	Not reported	Revenue: 0 Open source
2007-03-31	Operating margin	Not reported	Revenue: 0 Open source
2008-03-31	Operating margin	Not reported	Revenue: 0 Open source
2009-03-31	Operating margin	Not reported	Revenue: 0 Open source
2010-03-31	Operating margin	Not reported	Revenue: 0 Open source
20012001-12-31	Net margin	Not reported	Net Income: -65516 Open source Revenue: 0 Open source
20022002-12-31	Net margin	Not reported	Net Income: 575108 Open source Revenue: 0 Open source
20032003-12-31	Net margin	Not reported	Net Income: -18978 Open source Revenue: 0 Open source
20042004-12-31	Net margin	Not reported	Net Income: -24166 Open source Revenue: 0 Open source
20052005-03-31	Net margin	Not reported	Net Income: -43269 Open source Revenue: 0 Open source
20062006-03-31	Net margin	Not reported	Net Income: -206540 Open source Revenue: 0 Open source
20072007-03-31	Net margin	Not reported	Net Income: -805534 Open source Revenue: 0 Open source
20082008-03-31	Net margin	Not reported	Net Income: -5367187 Open source Revenue: 0 Open source
20092009-03-31	Net margin	Not reported	Net Income: -443288 Open source Revenue: 0 Open source
20102010-03-31	Net margin	Not reported	Net Income: -273402 Open source Revenue: 0 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -71429 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -28153 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20052005-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20062006-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20072007-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -26844 Open source
20082008-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -98256 Open source
20092009-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20102010-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -98.3K 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	-71429	Operating Cash Flow: -71429 Open source
20022002-12-31	Operating cash flow	-28153	Operating Cash Flow: -28153 Open source
20032003-12-31	Operating cash flow	Not reported	No source recorded
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-03-31	Operating cash flow	Not reported	No source recorded
20062006-03-31	Operating cash flow	Not reported	No source recorded
20072007-03-31	Operating cash flow	-26844	Operating Cash Flow: -26844 Open source
20082008-03-31	Operating cash flow	-98256	Operating Cash Flow: -98256 Open source
20092009-03-31	Operating cash flow	Not reported	No source recorded
20102010-03-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -71429 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -28153 Open source
20032003-12-31	Free cash flow	Unavailable	No source recorded
20042004-12-31	Free cash flow	Unavailable	No source recorded
20052005-03-31	Free cash flow	Unavailable	No source recorded
20062006-03-31	Free cash flow	Unavailable	No source recorded
20072007-03-31	Free cash flow	Unavailable	Operating Cash Flow: -26844 Open source
20082008-03-31	Free cash flow	Unavailable	Operating Cash Flow: -98256 Open source
20092009-03-31	Free cash flow	Unavailable	No source recorded
20102010-03-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	Total Assets: 75178 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2005-03-31	Liabilities / assets	Not reported	Total Assets: 135086 Open source
2006-03-31	Liabilities / assets	Not reported	Total Assets: 129829 Open source
2007-03-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2008-03-31	Liabilities / assets	Not reported	Total Assets: 103979 Open source
2009-03-31	Liabilities / assets	Not reported	Total Assets: 77610 Open source
2010-03-31	Liabilities / assets	Not reported	Total Assets: 76354 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	0.06×	Current Assets: 42648 Open source Current Liabilities: 716341 Open source
20022002-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 66055 Open source
20032003-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 85033 Open source
20042004-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 109199 Open source
20052005-03-31	Current assets / current liabilities	4.88×	Current Assets: 88553 Open source Current Liabilities: 18148 Open source
20062006-03-31	Current assets / current liabilities	0.48×	Current Assets: 128580 Open source Current Liabilities: 265305 Open source
20072007-03-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 25000 Open source
20082008-03-31	Current assets / current liabilities	0.04×	Current Assets: 7993 Open source Current Liabilities: 186401 Open source
20092009-03-31	Current assets / current liabilities	0.02×	Current Assets: 2336 Open source Current Liabilities: 149422 Open source
20102010-03-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 421568 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 65,516 Exact value Exact value: -65516 USD 2001-01-01 – 2001-12-31: -65516 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2001-12-31 Neuro Biotech Corp (edgar:894561) Net Income: -65516 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65516 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-03-000019.txt#1063 The citation records this snapshot. The page link may show a newer release later.	−USD 71,429 Exact value Exact value: -71429 USD 2001-01-01 – 2001-12-31: -71429 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Neuro Biotech Corp · 2001-12-31 Neuro Biotech Corp (edgar:894561) Operating Cash Flow: -71429 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -71429 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-03-000019.txt#1079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	USD 575,108 Exact value Exact value: 575108 USD 2002-01-01 – 2002-12-31: 575108 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2002-12-31 Neuro Biotech Corp (edgar:894561) Net Income: 575108 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 575108 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-04-000010.txt#845 The citation records this snapshot. The page link may show a newer release later.	−USD 28,153 Exact value Exact value: -28153 USD 2002-01-01 – 2002-12-31: -28153 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Neuro Biotech Corp · 2002-12-31 Neuro Biotech Corp (edgar:894561) Operating Cash Flow: -28153 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28153 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-03-000019.txt#1079 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 18,978 Exact value Exact value: -18978 USD 2003-01-01 – 2003-12-31: -18978 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2003-12-31 Neuro Biotech Corp (edgar:894561) Net Income: -18978 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18978 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-05-000018.txt#915 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 24,166 Exact value Exact value: -24166 USD 2004-01-01 – 2004-12-31: -24166 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2004-12-31 Neuro Biotech Corp (edgar:894561) Net Income: -24166 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24166 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-05-000018.txt#915 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2005 2004-04-01 – 2005-03-31	−USD 43,269 Exact value Exact value: -43269 USD 2004-04-01 – 2005-03-31: -43269 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2005-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -43269 USD Concept: fundies:NetIncome Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2005-03-31&surface=latest&period_type=duration&start=2004-04-01&unit=USD&dimensions= Input fundies:NetIncome: -43269 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-06-000084.txt#856 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2006 2005-04-01 – 2006-03-31	−USD 206,540 Exact value Exact value: -206540 USD 2005-04-01 – 2006-03-31: -206540 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2006-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -206540 USD Concept: fundies:NetIncome Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:NetIncome: -206540 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001016295-07-000043.txt#921 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2006-04-01 – 2007-03-31	−USD 805,534 Exact value Exact value: -805534 USD 2006-04-01 – 2007-03-31: -805534 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2007-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -805534 USD Concept: fundies:NetIncome Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:NetIncome: -805534 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-09-038945.txt#2825 The citation records this snapshot. The page link may show a newer release later.	−USD 26,844 Exact value Exact value: -26844 USD 2006-04-01 – 2007-03-31: -26844 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Neuro Biotech Corp · 2007-03-31 Neuro Biotech Corp (edgar:894561) Operating Cash Flow: -26844 USD Concept: fundies:OperatingCashFlow Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3AOperatingCashFlow&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26844 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-09-038945.txt#3125 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-04-01 – 2008-03-31	−USD 5.37 million Exact value Exact value: -5367187 USD 2007-04-01 – 2008-03-31: -5367187 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2008-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -5367187 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: -5367187 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-09-055442.txt#3652 The citation records this snapshot. The page link may show a newer release later.	−USD 98,256 Exact value Exact value: -98256 USD 2007-04-01 – 2008-03-31: -98256 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Neuro Biotech Corp · 2008-03-31 Neuro Biotech Corp (edgar:894561) Operating Cash Flow: -98256 USD Concept: fundies:OperatingCashFlow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -98256 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-09-038945.txt#3125 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-04-01 – 2009-03-31	−USD 443,288 Exact value Exact value: -443288 USD 2008-04-01 – 2009-03-31: -443288 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2009-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -443288 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: -443288 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#3578 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2009-04-01 – 2010-03-31	−USD 273,402 Exact value Exact value: -273402 USD 2009-04-01 – 2010-03-31: -273402 USD Inspect Net Income Open source Share or cite Citation for Net Income · Neuro Biotech Corp · 2010-03-31 Neuro Biotech Corp (edgar:894561) Net Income: -273402 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894561/explain?concept=fundies%3ANetIncome&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:NetIncome: -273402 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894561/0001144204-10-036427.txt#3578 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000894561, 894561, edgar:894561

Also known as M45 Mining Resources, Inc., QUANTITATIVE METHODS CORP

Neuro Biotech Corp

Latest quarter

Revenue

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2010 2009-04-01 – 2010-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation